{"title":"Systematic review of penile glans necrosis.","authors":"Hygor Franca Buss, Fabio Thadeu Ferreira, Thiago Guedes Giles, Thiely Guedes Giles","doi":"10.1093/jsxmed/qdaf251","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Penile glans necrosis is a rare, debilitating condition with significant cosmetic and functional consequences. Despite its clinical importance, no standardized treatment protocol exists owing to a lack of robust evidence and variability in management practices.</p><p><strong>Objectives: </strong>This systematic review aims to evaluate therapeutic interventions for penile glans ischemia and necrosis, identify gaps in current knowledge, and propose a framework for future clinical practice.</p><p><strong>Methods: </strong>In accordance with the PRISMA 2020 statement, a systematic search of PubMed was performed from March 2024 to May 2025 using predefined search terms related to penile glans ischemia and necrosis. The inclusion criteria focused on cases of ischemia caused by reduced blood flow, excluding those linked to infections, calciphylaxis, priapism, or immediate surgical interventions. Outcomes were classified by lesion extent and type (grades I-III, A-B), and statistical analyses explored associations between treatment modalities and outcomes. Risk of bias was assessed with the JBI and Risk Of Bias In Non-randomized Studies-of Interventions tools.</p><p><strong>Results: </strong>Data from 48 studies encompassing 79 patients were analyzed. Circumcision (n = 55) and prostatic artery embolization (n = 13) were the most common etiologies. Treatments varied widely, including hyperbaric oxygen therapy (44.94%), antibiotics (43.82%), surgical interventions (43.82%), and pentoxifylline (40.45%). While grade A ischemia was significantly associated with better outcomes (P < .001, odds ratio = 182.77), no single treatment modality demonstrated statistically superior efficacy when compared pairwise. Antibiotic therapy and surgical interventions were associated with worse outcomes, likely reflecting their use in more severe cases. Publication bias and heterogeneity in case descriptions posed challenges to definitive conclusions.</p><p><strong>Conclusion: </strong>Early recognition of ischemia significantly improves outcomes, highlighting the importance of prompt diagnosis and intervention, and the combination of pentoxifylline, hyperbaric oxygen therapy, anticoagulation, and topical agents may offer synergistic benefits. The findings of this review underscore the critical need for evidence-based protocols, standardized classification systems, consistent therapeutic strategies, and robust clinical trials; future research should focus on prospective studies with standardized methodologies to optimize care and improve functional and aesthetic outcomes for affected patients.</p>","PeriodicalId":51100,"journal":{"name":"Journal of Sexual Medicine","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Sexual Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/jsxmed/qdaf251","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Penile glans necrosis is a rare, debilitating condition with significant cosmetic and functional consequences. Despite its clinical importance, no standardized treatment protocol exists owing to a lack of robust evidence and variability in management practices.
Objectives: This systematic review aims to evaluate therapeutic interventions for penile glans ischemia and necrosis, identify gaps in current knowledge, and propose a framework for future clinical practice.
Methods: In accordance with the PRISMA 2020 statement, a systematic search of PubMed was performed from March 2024 to May 2025 using predefined search terms related to penile glans ischemia and necrosis. The inclusion criteria focused on cases of ischemia caused by reduced blood flow, excluding those linked to infections, calciphylaxis, priapism, or immediate surgical interventions. Outcomes were classified by lesion extent and type (grades I-III, A-B), and statistical analyses explored associations between treatment modalities and outcomes. Risk of bias was assessed with the JBI and Risk Of Bias In Non-randomized Studies-of Interventions tools.
Results: Data from 48 studies encompassing 79 patients were analyzed. Circumcision (n = 55) and prostatic artery embolization (n = 13) were the most common etiologies. Treatments varied widely, including hyperbaric oxygen therapy (44.94%), antibiotics (43.82%), surgical interventions (43.82%), and pentoxifylline (40.45%). While grade A ischemia was significantly associated with better outcomes (P < .001, odds ratio = 182.77), no single treatment modality demonstrated statistically superior efficacy when compared pairwise. Antibiotic therapy and surgical interventions were associated with worse outcomes, likely reflecting their use in more severe cases. Publication bias and heterogeneity in case descriptions posed challenges to definitive conclusions.
Conclusion: Early recognition of ischemia significantly improves outcomes, highlighting the importance of prompt diagnosis and intervention, and the combination of pentoxifylline, hyperbaric oxygen therapy, anticoagulation, and topical agents may offer synergistic benefits. The findings of this review underscore the critical need for evidence-based protocols, standardized classification systems, consistent therapeutic strategies, and robust clinical trials; future research should focus on prospective studies with standardized methodologies to optimize care and improve functional and aesthetic outcomes for affected patients.
期刊介绍:
The Journal of Sexual Medicine publishes multidisciplinary basic science and clinical research to define and understand the scientific basis of male, female, and couples sexual function and dysfunction. As an official journal of the International Society for Sexual Medicine and the International Society for the Study of Women''s Sexual Health, it provides healthcare professionals in sexual medicine with essential educational content and promotes the exchange of scientific information generated from experimental and clinical research.
The Journal of Sexual Medicine includes basic science and clinical research studies in the psychologic and biologic aspects of male, female, and couples sexual function and dysfunction, and highlights new observations and research, results with innovative treatments and all other topics relevant to clinical sexual medicine.
The objective of The Journal of Sexual Medicine is to serve as an interdisciplinary forum to integrate the exchange among disciplines concerned with the whole field of human sexuality. The journal accomplishes this objective by publishing original articles, as well as other scientific and educational documents that support the mission of the International Society for Sexual Medicine.